Walsh D A, Moran H W, Shamblee D A, Welstead W J, Nolan J C, Sancilio L F, Graff G
Department of Chemical Research, A.H. Robins Company, Richmond, Virginia 23261-6609.
J Med Chem. 1990 Aug;33(8):2296-304. doi: 10.1021/jm00170a039.
A series of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid (amfenac) and 2-amino-3-(4-chlorobenzoyl)benzeneacetic acid were synthesized and evaluated for their cyclooxygenase inhibiting properties, antiinflammatory potency, and gastrointestinal irritation liability. One compound, 2-amino-3-(4-chlorobenzoyl)benzeneacetamide, possessed a therapeutic index 1 order of magnitude greater than that of indomethacin.
合成了一系列2-氨基-3-苯甲酰基苯乙酸(氨芬酸)和2-氨基-3-(4-氯苯甲酰基)苯乙酸的潜在前药,并对其环氧合酶抑制特性、抗炎效力和胃肠道刺激倾向进行了评估。一种化合物,2-氨基-3-(4-氯苯甲酰基)苯乙酰胺,其治疗指数比吲哚美辛高1个数量级。